-
HD2026 Milton Wexler Biennial Symposium Day 3
Latest News
-
HD2026 Milton Wexler Biennial Symposium Day 2
⏱️ 23 min read | Day 2 of #HD2026 brought us updates on the mechanics of somatic instability, new ways to track HD in people, AI tools to help drive research forward, and developments in our understanding of the HTT protein. Catch up right here.
-
Major Roche-Isis deal boosts Huntington's disease gene silencing
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-
HD Therapeutics Conference 2013 Updates: Day 1
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-
Lost in translation? New insights into the making of the Huntington's disease protein
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-
Simple rules for a good night's sleep in Huntington's disease
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
-
Is a new technique set to revolutionize Huntington's disease genetic testing?
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
-
No surprises in published results from HART study of Huntexil for Huntington's disease
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
-
Liver changes in Huntington's disease patients suggest more 'whole body' research needed
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-
The 'N17' region of huntingtin protein: an address label in Huntington's disease?
New research sheds light on where the huntingtin protein ends up inside our cells, and why
-
HDBuzz Special Feature: Huntington's disease and sleep
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?
-
The University of New Orleans has NOT discovered a cure for Huntington's disease
The science behind an extraordinary press release claiming to have discovered 'A Way to Delay Symptoms of HD'
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Show 9 more Show less
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
